Ermertcan A.T.Aktas A.Öztürk F.Temiz P.2024-07-222024-07-22202100114162http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13313[No abstract available]EnglishAll Open Access; Bronze Open AccessHumansOmalizumabPeripheral Vascular DiseasesUrticariaVasculitisVasculitis, Leukocytoclastic, Cutaneousomalizumabhumanleukocytoclastic vasculitisperipheral vascular diseaseurticariavasculitisUrticarial vasculitis successfully treated with omalizumabLetter10.12788/cutis.0272